Adrian V S Hill Selected Research

Malaria

10/2022	Production of a high purity, C-tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditions.
1/2022	Deep Immune Phenotyping and Single-Cell Transcriptomics Allow Identification of Circulating TRM-Like Cells Which Correlate With Liver-Stage Immunity and Vaccine-Induced Protection From Malaria.
4/2021	A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development.
1/2021	Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.
1/2021	Poor CD4+ T Cell Immunogenicity Limits Humoral Immunity to P. falciparum Transmission-Blocking Candidate Pfs25 in Humans.
1/2021	Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.
1/2021	Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice.
1/2021	Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites.
1/2020	Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule.
1/2020	Generation of Novel Plasmodium falciparum NF135 and NF54 Lines Expressing Fluorescent Reporter Proteins Under the Control of Strong and Constitutive Promoters.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adrian V S Hill Research Topics

Disease

150	Malaria 10/2022 - 01/2002
66	Infections 10/2021 - 04/2003
38	Tuberculosis (Tuberculoses) 01/2020 - 03/2002
18	Vaccinia 03/2021 - 10/2007
18	Communicable Diseases (Infectious Diseases) 03/2020 - 07/2007
13	Human Influenza (Influenza) 01/2022 - 01/2011
12	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2021 - 01/2005
9	Bites and Stings (Sting) 01/2019 - 02/2005
8	Parasitemia 01/2020 - 06/2003
7	COVID-19 12/2021 - 01/2020
7	Fowlpox 12/2009 - 06/2004
6	Neoplasms (Cancer) 01/2018 - 12/2005
6	Acquired Immunodeficiency Syndrome (AIDS) 03/2012 - 05/2002
5	HIV Infections (HIV Infection) 01/2021 - 04/2006
5	Inflammation (Inflammations) 01/2020 - 12/2003
5	Sepsis (Septicemia) 03/2017 - 03/2011
5	Pneumococcal Infections 01/2015 - 05/2002
4	Pain (Aches) 12/2021 - 01/2011
4	Fever (Fevers) 10/2021 - 11/2007
4	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2016
4	Rift Valley Fever 01/2019 - 12/2013
4	Hepatitis B 06/2015 - 01/2005
3	Anemia 01/2019 - 01/2013
3	Bacteremia 01/2019 - 06/2016
3	Persistent Infection 08/2016 - 09/2003
2	Headache (Headaches) 12/2021 - 01/2020
2	Ageusia (Hypogeusia) 10/2021 - 01/2021
2	Dyspnea (Shortness of Breath) 10/2021 - 01/2021
2	Cough 10/2021 - 01/2021
2	Anosmia 10/2021 - 01/2021
2	Rheumatic Heart Disease (Rheumatic Heart Diseases) 01/2020 - 11/2017
2	Ebola Hemorrhagic Fever 01/2019 - 01/2018
2	Rabies (Hydrophobia) 10/2018 - 12/2009
2	Parasitic Diseases (Parasitic Disease) 09/2016 - 10/2011
2	Chronic Hepatitis C 08/2016 - 05/2016
2	Vesicular Stomatitis 04/2016 - 03/2007

Drug/Important Bio-Agent (IBA)

165	VaccinesIBA 10/2022 - 01/2002
77	AntigensIBA 01/2022 - 03/2002
50	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2003
31	Malaria VaccinesIBA 01/2021 - 01/2002
20	EpitopesIBA 01/2018 - 03/2002
15	ThrombospondinsIBA 01/2018 - 04/2003
15	MVA 85AIBA 01/2013 - 07/2004
14	AntibodiesIBA 01/2022 - 08/2008
13	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 12/2019 - 06/2012
11	Peptides (Polypeptides)IBA 04/2021 - 03/2004
11	DNA (Deoxyribonucleic Acid)IBA 02/2011 - 06/2003
10	CytokinesIBA 03/2017 - 12/2004
9	Subunit VaccinesIBA 12/2015 - 01/2004
9	Merozoite Surface Protein 1 (MSA1)IBA 04/2014 - 03/2002
6	ChAdOx1 nCoV-19IBA 12/2021 - 01/2020
6	Pharmaceutical PreparationsIBA 01/2020 - 08/2006
6	Antimalarials (Antimalarial Agents)IBA 01/2016 - 03/2007
5	Nucleic AcidsIBA 10/2021 - 01/2014
5	Interferon-gamma (Interferon, gamma)IBA 06/2012 - 04/2003
5	Tuberculosis VaccinesIBA 06/2011 - 05/2006
4	Neutralizing AntibodiesIBA 04/2021 - 12/2011
4	IronIBA 01/2020 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2013
4	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2010 - 03/2004
3	EnzymesIBA 01/2020 - 11/2005
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 02/2005
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 07/2007
3	Rabies Vaccines (Rabies Vaccine)FDA Link 10/2018 - 05/2015
3	Glycoproteins (Glycoprotein)IBA 07/2017 - 01/2016
3	Antiviral Agents (Antivirals)IBA 08/2016 - 07/2012
3	InterferonsIBA 05/2015 - 06/2003
3	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2014 - 06/2012
3	LigandsIBA 02/2013 - 12/2003
3	Viral VaccinesIBA 03/2011 - 12/2007
3	HLA-DRB1 Chains (HLA DRB1)IBA 07/2010 - 06/2005
3	Synthetic Vaccines (Recombinant Vaccines)IBA 04/2009 - 02/2005
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2022 - 07/2005
2	MenACWYIBA 10/2021 - 01/2020
2	Matrix-MIBA 01/2021 - 01/2018
2	Transferrin (beta 2 Transferrin)IBA 01/2020 - 01/2019
2	Cancer VaccinesIBA 01/2020 - 01/2016
2	Luminescent ProteinsIBA 01/2020 - 01/2019
2	Ebola VaccinesIBA 01/2020 - 01/2019
2	Ferritins (Ferritin)IBA 01/2020 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 01/2019 - 01/2013
2	HepcidinsIBA 01/2019 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2019 - 09/2010
2	Immune Checkpoint InhibitorsIBA 01/2018 - 07/2017
2	artemisinin (artemisinine)IBA 01/2018 - 12/2015
2	Immunoglobulin G (IgG)IBA 01/2017 - 12/2011
2	Long Noncoding RNAIBA 06/2016 - 02/2013
2	Adenovirus VaccinesIBA 02/2016 - 01/2013
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 09/2015 - 01/2010
2	Interleukin-4 (Interleukin 4)IBA 05/2015 - 05/2007
2	Interleukin-2 (IL2)IBA 05/2015 - 11/2006
2	VirosomesIBA 05/2015 - 12/2009
2	N-acetyltalosaminuronic acid (NAT)IBA 01/2015 - 01/2014
2	Recombinant ProteinsIBA 12/2014 - 01/2012

Therapy/Procedure

7	Therapeutics 01/2018 - 07/2010
5	Immunotherapy 01/2020 - 01/2016
2	Intramuscular Injections 01/2020 - 01/2014
2	Critical Care (Surgical Intensive Care) 01/2017 - 01/2016
2	Precision Medicine 01/2017 - 01/2016
2	Insecticide-Treated Bednets 12/2015 - 01/2004